ArticleBMC cancer2025

Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study.

Jun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.